Literature DB >> 35404811

Disentangling Normal Aging From Severity of Disease via Weak Supervision on Longitudinal MRI.

Jiahong Ouyang, Qingyu Zhao, Ehsan Adeli, Greg Zaharchuk, Kilian M Pohl.   

Abstract

The continuous progression of neurological diseases are often categorized into conditions according to their severity. To relate the severity to changes in brain morphometry, there is a growing interest in replacing these categories with a continuous severity scale that longitudinal MRIs are mapped onto via deep learning algorithms. However, existing methods based on supervised learning require large numbers of samples and those that do not, such as self-supervised models, fail to clearly separate the disease effect from normal aging. Here, we propose to explicitly disentangle those two factors via weak-supervision. In other words, training is based on longitudinal MRIs being labelled either normal or diseased so that the training data can be augmented with samples from disease categories that are not of primary interest to the analysis. We do so by encouraging trajectories of controls to be fully encoded by the direction associated with brain aging. Furthermore, an orthogonal direction linked to disease severity captures the residual component from normal aging in the diseased cohort. Hence, the proposed method quantifies disease severity and its progression speed in individuals without knowing their condition. We apply the proposed method on data from the Alzheimer's Disease Neuroimaging Initiative (ADNI, N =632 ). We then show that the model properly disentangled normal aging from the severity of cognitive impairment by plotting the resulting disentangled factors of each subject and generating simulated MRIs for a given chronological age and condition. Moreover, our representation obtains higher balanced accuracy when used for two downstream classification tasks compared to other pre-training approaches. The code for our weak-supervised approach is available at https://github.com/ouyangjiahong/longitudinal-direction-disentangle.

Entities:  

Mesh:

Year:  2022        PMID: 35404811      PMCID: PMC9578549          DOI: 10.1109/TMI.2022.3166131

Source DB:  PubMed          Journal:  IEEE Trans Med Imaging        ISSN: 0278-0062            Impact factor:   11.037


  43 in total

1.  Predicting Alzheimer's conversion in mild cognitive impairment patients using longitudinal neuroimaging and clinical markers.

Authors:  Carlos Platero; M Carmen Tobar
Journal:  Brain Imaging Behav       Date:  2020-11-10       Impact factor: 3.978

Review 2.  Non-psychiatric comorbidity associated with Alzheimer's disease.

Authors:  A Duthie; D Chew; R L Soiza
Journal:  QJM       Date:  2011-07-18

3.  Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects.

Authors:  Abhinay D Joshi; Michael J Pontecorvo; Chrisopher M Clark; Alan P Carpenter; Danna L Jennings; Carl H Sadowsky; Lee P Adler; Karel D Kovnat; John P Seibyl; Anupa Arora; Krishnendu Saha; Jason D Burns; Mark J Lowrey; Mark A Mintun; Daniel M Skovronsky
Journal:  J Nucl Med       Date:  2012-02-13       Impact factor: 10.057

Review 4.  The Alzheimer's disease neuroimaging initiative.

Authors:  Susanne G Mueller; Michael W Weiner; Leon J Thal; Ronald C Petersen; Clifford Jack; William Jagust; John Q Trojanowski; Arthur W Toga; Laurel Beckett
Journal:  Neuroimaging Clin N Am       Date:  2005-11       Impact factor: 2.264

5.  Self-Supervised Longitudinal Neighbourhood Embedding.

Authors:  Jiahong Ouyang; Qingyu Zhao; Ehsan Adeli; Edith V Sullivan; Adolf Pfefferbaum; Greg Zaharchuk; Kilian M Pohl
Journal:  Med Image Comput Comput Assist Interv       Date:  2021-09-21

6.  Label-aligned multi-task feature learning for multimodal classification of Alzheimer's disease and mild cognitive impairment.

Authors:  Chen Zu; Biao Jie; Mingxia Liu; Songcan Chen; Dinggang Shen; Daoqiang Zhang
Journal:  Brain Imaging Behav       Date:  2016-12       Impact factor: 3.978

Review 7.  Structural and functional MRI in mild cognitive impairment.

Authors:  Maija Pihlajamäki; Anne M Jauhiainen; Hilkka Soininen
Journal:  Curr Alzheimer Res       Date:  2009-04       Impact factor: 3.498

8.  The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.

Authors:  Clifford R Jack; Matt A Bernstein; Nick C Fox; Paul Thompson; Gene Alexander; Danielle Harvey; Bret Borowski; Paula J Britson; Jennifer L Whitwell; Chadwick Ward; Anders M Dale; Joel P Felmlee; Jeffrey L Gunter; Derek L G Hill; Ron Killiany; Norbert Schuff; Sabrina Fox-Bosetti; Chen Lin; Colin Studholme; Charles S DeCarli; Gunnar Krueger; Heidi A Ward; Gregory J Metzger; Katherine T Scott; Richard Mallozzi; Daniel Blezek; Joshua Levy; Josef P Debbins; Adam S Fleisher; Marilyn Albert; Robert Green; George Bartzokis; Gary Glover; John Mugler; Michael W Weiner
Journal:  J Magn Reson Imaging       Date:  2008-04       Impact factor: 4.813

9.  Landmark-based deep multi-instance learning for brain disease diagnosis.

Authors:  Mingxia Liu; Jun Zhang; Ehsan Adeli; Dinggang Shen
Journal:  Med Image Anal       Date:  2017-10-27       Impact factor: 8.545

Review 10.  Dissociating Normal Aging from Alzheimer's Disease: A View from Cognitive Neuroscience.

Authors:  Max Toepper
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.